MENU
AVBP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ArriVent BioPharma (AVBP) Earnings Date & Reports

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more

A.I. Advisor
published Earnings

AVBP is expected to report earnings to fall 1.20% to -81 cents per share on March 26

ArriVent BioPharma AVBP Stock Earnings Reports
Q4'25
Est.
$-0.82
Q3'25
Missed
by $0.04
Q2'25
Missed
by $0.14
Q1'25
Missed
by $1.17
Q4'24
Missed
by $0.14
The last earnings report on November 10 showed earnings per share of -82 cents, missing the estimate of -79 cents. With 77.00K shares outstanding, the current market capitalization sits at 920.16M.
View a ticker or compare two or three
AVBP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AVBP showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18 Campus Boulevard
Phone
+1 628 277-4836
Employees
40
Web
https://arrivent.com